Análisis Argos
AVTR
AVTRBarata · ojo al riesgo
Avantor, Inc. · Healthcare
US$ 10.32
precio al 2026-07-04
Valor justo Argos*
US$ 13–15
vs. su valor justo
25% por debajo
Score Argos
51/100
Barata · ojo al riesgo
LA RESPUESTA
El mercado la precia para que se encoja 8.9% al año — menos de lo que viene demostrando (1%). Un negocio de calidad castigado por expectativas pesimistas: por eso está entre las llamadas de Argos. Ojo: tiene señales de riesgo en sus números — es barata con asterisco.
Recompensas
Cotiza por debajo de su valor justo: el mercado le pide menos crecimiento del que viene demostrando.
Riesgos
!Balance frágil: la deuda pesa sobre el negocio.
VALOR4/6FUTURO4/6PASADO0/6SALUD1/6DIVIDENDO2/6
El Iris de calidad
VALOR4/6FUTURO4/6PASADO0/6SALUD1/6DIVIDENDO2/6
ValorCotiza por debajo de su valor justo
FuturoIngresos creciendo con fuerza
PasadoHistorial débil
SaludBalance frágil
DividendoRetorno al accionista moderado
Score Argos51de 100Barata · ojo al riesgo
Ingresos3%
US$ 6.6 B
Margen operativo124%
-3.8%
Flujo de caja libre29%
US$ 0.5 B
Deuda neta
US$ 3.6 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 7.0B
P/E
EV/EBITDA64.8x
FCF yield7%
ROIC-2.7%
Margen operativo-3.8%
Crecim. ingresos-3.4%/año
Piotroski F4/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

prnewswire.com · 1 jul
Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026
RADNOR, Pa., July 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its second quarter 2026 financial results before the market opens on Wednesday, July 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m.
zacks.com · 29 may
Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?
zacks.com · 29 may
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.
prnewswire.com · 19 may
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
RADNOR, Pa., May 19, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.
zacks.com · 30 abr
Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline
AVTR benefits from stable Q1 revenues and improving demand trends, though margin pressure and volume softness weigh on profitability.
seekingalpha.com · 30 abr
Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible
Avantor, Inc. reported a slight beat on 1Q26 EPS and revenue, but underlying organic growth and margins remain under pressure. Negative organic growth, margin compression, and subdued cash flow signal only early stabilization, not a confirmed recovery, especially in the VWR segment. Management reaffirmed 2026 guidance and expects sequential improvement, but the recovery is execution-dependent and gradual, with margins likely to remain below historical peaks.
seekingalpha.com · 29 abr
Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript
Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript
zacks.com · 29 abr
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.23 per share a year ago.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.